Abstract / Summary
Coronary artery disease (CAD) remains the most prevalent cardiovascular disorder and a leading cause of global morbidity and mortality. It is primarily driven by atherosclerotic plaque accumulation within the coronary arteries, resulting in impaired myocardial perfusion and potentially leading to ischemia, myocardial infarction, or sudden cardiac death. This study aimed to evaluate the performance of two deep convolutional neural network (CNN) architectures (DenseNet121 and ResNet50) for automated detection of CAD using multiparametric cardiac magnetic resonance (CMR) imaging. Model validation was performed using multiparametric CMR datasets (cine, T1 mapping, T2 mapping, and late gadolinium enhancement sequences) used as input for all training and evaluation procedures. Performance was assessed using a rigorous evaluation protocol consisting of 50 independent runs of 10 fold cross validation. Evaluation metrics included average classification accuracy (ACA), area under the receiver operating characteristic curve (AUC ROC), precision–recall AUC (PR AUC), and performance variability quantified by standard deviation. ResNet50 demonstrated superior performance and greater stability compared with DenseNet121, achieving an ACA of 92% (95% CI: 91–93%), an AUC ROC of 0.96 (95% CI: 0.95–0.97), and a PR AUC of 0.89 (95% CI: 0.87–0.91). In contrast, DenseNet121 achieved an ACA of 80% (95% CI: 78–82%) and an AUC ROC of 0.89 (95% CI: 0.87–0.91). These results indicate that ResNet50 consistently outperformed DenseNet121 across all validation metrics, with narrower confidence intervals reflecting greater robustness and reduced performance variability. The findings support the use of ResNet50 as a more reliable architecture for CAD detection from multiparametric CMR data. Given the clinical importance of early and accurate CAD identification—particularly for guiding timely intervention and risk stratification—these results highlight the potential of well validated deep learning models to enhance diagnostic workflows and support clinical decision making in cardiovascular imaging.
Topics
Primary Source
Applied Medical Informatics
Ask Prognia AI
Have questions about this review article?
Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.
Related Clinical Guidelines
Related Blog Posts
ESC 2023 Heart Failure Guidelines: What Every Cardiologist Needs to Know
The 2023 focused update to the ESC Heart Failure Guidelines introduced key changes to SGLT2 inhibitor recommendations, HFmrEF management, and device therapy thresholds. Here is a practical summary.
CHADS₂-VASc in Practice: When to Start Anticoagulation in AF
A practical walkthrough of the CHADS₂-VASc scoring system, its ESC guideline thresholds, and how to use it alongside HAS-BLED to counsel patients with atrial fibrillation.